Supriya Lifescience has informed that it enclosed Outcome of voting results of 16th Annual General Meeting held on September 27, 2024 as per Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Consolidated Scrutinizer's Report (Remote E-voting Result and E-voting during the AGM). Based on the Combined Report from the Scrutinizer (annexed), M/s. DSM & Associates, Company Secretary in Practice, all the resolutions as set out in the Notice of the 16th AGM have been approved by the members with requisite majority.
The above information is a part of company’s filings submitted to BSE.
